5.1 Toxicology, Exposure, Risk & LD50/LC50

Toxicology, Exposure, and Risk

Toxicity is a substance's inherent ability to cause harm. Hazard combines toxicity with the circumstances of exposure, and risk considers both the likelihood and severity of that harm. A highly toxic product in a closed, well-controlled system can present less risk than a less toxic product repeatedly contacting bare skin. Applicators reduce risk mainly by preventing exposure and following label controls.

Dose and response

“The dose makes the poison” means effects depend on how much reaches the body, by what route, and for how long. A dose-response study exposes groups of test organisms to defined amounts and observes effects. A NOAEL is the highest tested dose at which a study found no observed adverse effect; it is not proof that a universal biological threshold exists for every person or endpoint. A LOAEL is the lowest tested dose at which an adverse effect was observed.

Individual response varies with age, health, genetics, hydration, medications, pregnancy, prior exposure, and route. Product formulation also matters because solvents, particle size, and other ingredients can change absorption.

Acute and chronic effects

Acute effects follow a single exposure or several exposures over a short period. They can include irritation, headache, nausea, sweating, breathing difficulty, confusion, seizures, or collapse. “Acute” describes timing, not severity; an acute exposure can be mild or fatal.

Chronic effects arise after repeated or long-duration exposure and may appear after a latency period. Depending on the chemical, concerns can involve the nervous system, liver, kidneys, reproduction, development, endocrine function, or cancer. Do not infer chronic risk only from the front-panel signal word. Signal words primarily communicate acute toxicity or irritation of the formulated product.

Local effects occur at the contact site, such as skin irritation or corrosive eye injury. Systemic effects occur after absorption and distribution through the body. Allergic sensitization is different from ordinary irritation: after sensitization, a small later exposure may trigger a strong response.

LD50 and LC50

LD50 is a statistically estimated dose expected to kill 50 percent of a test population under stated conditions. It is usually expressed as milligrams of test material per kilogram of body weight. Oral and dermal LD50 values are separate because absorption differs by route.

LC50 is a concentration expected to kill 50 percent of a test population during a specified exposure. It is used for air or water exposure and must be interpreted with its units, species, route, and duration. Do not assume every inhalation LC50 uses the same exposure time.

The relationship is inverse:

• a lower LD50 or LC50 indicates greater acute lethality under the test conditions;
• a higher value indicates lower acute lethality under those conditions.

These values compare acute lethality; they do not predict skin corrosion, allergy, chronic effects, environmental toxicity, or the exact dose that would harm a human. The formulation's product toxicity can differ from the active ingredient alone.

EPA acute toxicity categories and signal words

EPA assigns acute toxicity categories from I through IV using oral, dermal, inhalation, eye, and skin data. The most severe applicable acute endpoint generally drives the signal word.

• Category I uses DANGER. If Category I is based on acute oral, dermal, or inhalation lethality, POISON and the skull-and-crossbones also appear.
• Category II uses WARNING.
• Category III uses CAUTION.
• Category IV may use CAUTION or may omit a signal word under EPA policy.

DANGER without POISON can reflect severe irreversible eye or skin damage rather than the highest systemic lethality. The label—not container color, odor, or product familiarity—is the authority.

Routes of exposure

Four routes dominate applicator safety:

1. Dermal: splashes, leaks, contaminated gloves, wet clothing, and contact with residues.
2. Ocular: concentrate splash, dust, mist, or contaminated hands touching the eyes.
3. Inhalation: dusts, droplets, vapors, gases, or fumigants.
4. Oral: contaminated food, drink, tobacco, hands, or accidental transfer to an unlabeled container.

Dermal exposure is often the most common occupational route, but do not memorize a universal percentage or a table claiming exact absorption for every body site and pesticide. Skin condition, temperature, formulation, contact time, and body location all affect absorption. Eyes, groin, scalp, and damaged skin deserve prompt protection and decontamination, but exact percentages are chemical-specific.

Risk reduction

Risk falls when exposure falls. Substitute a less hazardous effective product or method, use closed transfer or engineering controls, maintain equipment, wear label PPE, keep hands clean, separate food and drink, and stop leaks promptly. PPE is the final barrier, not permission to ignore other controls.

If symptoms occur, stop work, move away from exposure without endangering a rescuer, follow the product's first-aid directions, and obtain medical or poison-control advice. Bring the label or EPA registration number. Do not diagnose toxicity from LD50 tables or wait for symptoms to become severe.